Outside Interest Disclosure
Outside Interest Disclosure
Complete transparency and full disclosure play a key role in reducing, eliminating, or managing conflicts of commitment and conflicts of interest, whether real or perceived.
Who Must Complete a Disclosure Using the Link Below?
WFBMC controlled affiliates as well as community physicians with admitting privileges and their exempt employees must complete an annual outside interest disclosure each April per WFBMC policy.
The Outside Interest Disclosure Process is automated and available online at the link below. We recommend using the Instructions link and printing for first time users or if you need a refresher. To log in, type your Medical Center User ID and password.
What must I disclose?
According to the WFBMC policy, each individual will annually disclose any private relationship with an outside entity related to their medical center activities, regardless of the value. Any intellectual property rights (e.g., patents, copyrights, and current/potential future royalties from such rights), as well as any fiduciary services (e.g., officer or board member of an outside entity), must also be reported. In addition, time commitments outside the medical center must be reported regardless of amount of remuneration, number of days, time of the day, or day of the week.
What if my relationships change?
Disclosures must be kept current. When substantial changes in external activities occur, individuals are required to update their disclosure within 30 days. Select the appropriate link above to revise your disclosure. Each disclosure submission is individually date stamped and archived.
What other disclosures might be required?
In addition to the annual disclosure, faculty members and exempt employees must disclose outside interests through submission of grants, contracts, regulatory protocols, and purchases at the time of each new application. Certain third party-paid information is also required to be disclosed prior to travel.
Many publications require disclosure of financial interests at the time of manuscript submission, and presentations should generally include a brief disclosure on the first or second slide.
Beginning August 1, 2013, companies that manufacture drugs, medical devices and biologics will be required to comply with the Sunshine Act, a provision of the Affordable Care Act. The Act requires that detailed information about payments and other "transfers of value" worth over $10 from manufacturers to physicians and teaching hospitals be disclosed to the public in 2014. The information will be reported to Centers for Medicare and Medicaid Services and posted on a publicly accessible website known as Open Payments.
Contact our office with questions about your disclosure. Phone: 336-716-9300